SKI Market

Indian Indices

Sensex

83,576.24 -604.72
( -0.72%)

Global Indices

Nasdaq

49,520.87 233.75
(0.47%)

Dow Jones

6,986.78 44.32
(0.64%)

Hang Seng

51,918.01 800.75
(1.57%)

Nikkei 225

10,123.15 78.46
(0.78%)

Forex

USD-INR

89.91 -0.02
(-0.02%)

EUR-INR

104.90 -0.20
(-0.19%)

GBP-INR

120.86 -0.43
(-0.35%)

JPY-INR

0.57 0.00
(-0.15%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Ajanta Pharma Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

532331

INE031B01049

330.3875196

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

AJANTPHARM

36.38

34577.81

EPS(TTM)

Face Value()

Div & Yield %

76.07

1.02

Back

BIL Vyapar reports consolidated net loss of Rs 0.81 crore in the September 2025 quarter

Nov 12,2025

Net Loss of BIL Vyapar reported to Rs 0.81 crore in the quarter ended September 2025 as against net loss of Rs 0.55 crore during the previous quarter ended September 2024. There were no Sales reported in the quarter ended September 2025 and during the previous quarter ended September 2024.

83,576.24 -604.72 ( -0.72%)

49,520.87 233.75 (0.47%)

6,986.78 44.32 (0.64%)

51,918.01 800.75 (1.57%)

10,123.15 78.46 (0.78%)

89.91 -0.02 (-0.02%)

104.90 -0.20 (-0.19%)

120.86 -0.43 (-0.35%)

0.57 0.00 (-0.15%)